• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种新的耐多药结核病耻辱量表的心理测量学评估。

Psychometric evaluation of a new drug-resistant tuberculosis stigma scale.

机构信息

The University of Sydney Central Clinical School, The Faculty of Medicine and Health, The University of Sydney, 92-95 Parramatta Road, Camperdown, New South Wales 2050, Australia; The Woolcock Institute of Medical Research, Apartment 203, Building 2G, Van Phuc Diplomatic Compound 298 Kim Ma Street Ba Dinh District, Hanoi, Vietnam.

Department of Public Health, Institute for Tropical Medicine, Kronenburgstraat 43, 2000 Antwerp, Belgium.

出版信息

J Clin Epidemiol. 2021 May;133:101-110. doi: 10.1016/j.jclinepi.2021.01.007. Epub 2021 Jan 19.

DOI:10.1016/j.jclinepi.2021.01.007
PMID:33476766
Abstract

OBJECTIVES

Stigma contributes to diagnostic delay, disease concealment, and reduced wellbeing for people with multidrug-resistant tuberculosis (MDR-TB) and their communities. Despite the negative effects of stigma, there are no scales to measure stigma in people with MDR-TB. This study aimed to develop and validate a scale to measure stigma in people affected by MDR-TB in Vietnam.

STUDY DESIGN AND SETTING

People with rifampicin-resistant (RR)-MDR-TB who had completed at least 3 months of treatment were invited to complete a survey containing 45 draft stigma items. Data analysis included exploratory factor analysis, internal consistency, content, criterion and construct validity, and test-retest reliability.

RESULTS

A total of 315 people with RR/MDR-TB completed the survey. Exploratory factor analysis revealed a 14 item RR/MDR-TB stigma scale with four subscales, including guilt, social exclusion, physical isolation, and blame. Internal consistency and test-retest reliability were good (Cronbach's Alpha = 0.76, ICC = 0.92). Construct validity was adequate with moderate correlations with related constructs.

CONCLUSION

Our RR/MDR-TB Scale demonstrated good psychometric properties in Vietnam. This scale will assist in the measurement of stigma in people with RR/MDR-TB. It will also aid in the evaluation of stigma reduction interventions in people with RR/MDR-TB.

摘要

目的

污名化会导致耐多药结核病(MDR-TB)患者及其所在社区的诊断延误、疾病隐瞒和幸福感降低。尽管污名化有负面影响,但目前还没有专门用于衡量 MDR-TB 患者污名化的量表。本研究旨在开发和验证一种用于衡量越南 MDR-TB 患者污名化的量表。

研究设计和地点

已完成至少 3 个月 RR-MDR-TB 治疗的 RR-MDR-TB 患者受邀完成一项包含 45 个草案污名项目的调查。数据分析包括探索性因素分析、内部一致性、内容、标准和结构有效性以及测试-重测信度。

结果

共有 315 名 RR/MDR-TB 患者完成了调查。探索性因素分析显示,RR/MDR-TB 污名量表有 14 个项目,分为四个亚量表,包括内疚、社会排斥、身体隔离和指责。内部一致性和测试-重测信度良好(Cronbach's Alpha = 0.76,ICC = 0.92)。结构有效性适度,与相关结构呈中度相关。

结论

我们的 RR/MDR-TB 量表在越南具有良好的心理测量学特性。该量表将有助于衡量 RR/MDR-TB 患者的污名化。它还将有助于评估 RR/MDR-TB 患者减少污名化干预的效果。

相似文献

1
Psychometric evaluation of a new drug-resistant tuberculosis stigma scale.一种新的耐多药结核病耻辱量表的心理测量学评估。
J Clin Epidemiol. 2021 May;133:101-110. doi: 10.1016/j.jclinepi.2021.01.007. Epub 2021 Jan 19.
2
Adaptation and validation of the Van Rie tuberculosis stigma scale in Vietnam.越南结核病污名量表的适应和验证。
Int J Infect Dis. 2022 Jan;114:97-104. doi: 10.1016/j.ijid.2021.10.040. Epub 2021 Oct 29.
3
Depression, stigma and quality of life in people with drug-susceptible TB and drug-resistant TB in Vietnam.越南药物敏感性结核病和耐药性结核病患者的抑郁、污名和生活质量。
Int J Tuberc Lung Dis. 2021 Jun 1;25(6):461-467. doi: 10.5588/ijtld.20.0952.
4
Evaluation of Xpert MTB-RIF guided diagnosis and treatment of rifampicin-resistant tuberculosis in Indonesia: A retrospective cohort study.评估 Xpert MTB-RIF 指导下的耐利福平结核病的诊断和治疗:一项回顾性队列研究。
PLoS One. 2019 Feb 28;14(2):e0213017. doi: 10.1371/journal.pone.0213017. eCollection 2019.
5
High rates of multidrug-resistant and rifampicin-resistant tuberculosis among re-treatment cases: where do they come from?复治病例中耐多药和耐利福平结核病的高发生率:其来源何在?
BMC Infect Dis. 2017 Jan 6;17(1):36. doi: 10.1186/s12879-016-2171-1.
6
Effect of Xpert MTB/RIF on the treatment of multi-drug-resistant or rifampicin-resistant tuberculosis screened out from re-treatment pulmonary tuberculosis patients, a prospective cohort study.Xpert MTB/RIF对从复治肺结核患者中筛查出的耐多药或利福平耐药结核病治疗效果的前瞻性队列研究。
Ann Palliat Med. 2020 Mar;9(2):239-246. doi: 10.21037/apm.2020.02.17. Epub 2020 Mar 17.
7
Stigma towards people with tuberculosis: a cross-cultural adaptation and validation of a scale in Indonesia.针对结核病患者的污名化:印度尼西亚跨文化适应和量表验证。
BMC Psychol. 2023 Apr 13;11(1):112. doi: 10.1186/s40359-023-01161-y.
8
Prevalence and risk factors of anxiety and depression in patients with multi-drug/rifampicin-resistant tuberculosis.耐多药/利福平耐药结核病患者的焦虑和抑郁患病率及相关因素。
Front Public Health. 2024 Mar 27;12:1372389. doi: 10.3389/fpubh.2024.1372389. eCollection 2024.
9
Impact of scaling up Xpert MTB/RIF testing for the detection of rifampicin-resistant TB cases in Karachi, Pakistan.在巴基斯坦卡拉奇扩大 Xpert MTB/RIF 检测以发现利福平耐药结核病例的影响。
Int J Tuberc Lung Dis. 2018 Aug 1;22(8):899-904. doi: 10.5588/ijtld.17.0729.
10
Different profiles of body mass index variation among patients with multidrug-resistant tuberculosis: a retrospective cohort study.耐多药结核病患者体重指数变化的不同特征:一项回顾性队列研究。
BMC Infect Dis. 2020 Apr 28;20(1):315. doi: 10.1186/s12879-020-05028-0.

引用本文的文献

1
The effects of stigma and social support on the health-related quality of life of people with drug resistance tuberculosis in Lagos, Nigeria.耻辱感和社会支持对尼日利亚拉各斯耐多药结核病患者健康相关生活质量的影响。
Qual Life Res. 2025 May;34(5):1305-1316. doi: 10.1007/s11136-025-03902-5. Epub 2025 Feb 18.
2
Psychometric Characteristics of the Chinese Version of the Tuberculosis Related-Stigma Scale in a Population of Medical Students and Its Correlation with Selected Demographic Characteristics.医学生群体中中文版结核病相关耻辱感量表的心理测量特征及其与选定人口统计学特征的相关性
Risk Manag Healthc Policy. 2024 Apr 5;17:815-826. doi: 10.2147/RMHP.S446068. eCollection 2024.